Sabbin Bayanai Akan Maganin Cutar Alzheimer

A KYAUTA Kyauta 8 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Halia Therapeutics ta gabatar da bayanai a yau kan shirinta na hanawa na NLRP3 a babban taron Ci gaban Magungunan Jiki na Shekara-shekara na 10 na yau.

Dokta David J. Bearss, Shugaba, da Shugaba na Halia Therapeutics, ya nuna sakamakon da ke nuna yadda yin amfani da tsarin ƙaddamar da ƙaddamarwa ga wani ɓangaren NLRP3 hadaddun ya ba da damar tsara sabon nau'in mahadi waɗanda ke ƙaddamar da kunnawa da aiki na NLRP3 duka. Waɗannan ƙananan magungunan ƙwayoyin cuta suna da yuwuwar kaiwa ga yawancin alamun kumburin ƙwayoyin cuta da cututtukan jijiya. Dr. Bearss' gabatarwa yana da taken, "Targeting the NLRP3 Inflammasome for the Treatment of Alzheimer's Disease." An gudanar da taron a Boston Park Plaza, Boston, Massachusetts, daga Maris 28 zuwa 30, 2022.

“Bayanan da dabarun da aka gabatar a yau suna wakiltar sabon tsari don niyya NLRP3. Muna matukar farin ciki game da gano allosteric modulators na NLRP3 mai kumburi, kuma muna ci gaba da shirye-shirye da yawa zuwa asibitin ta amfani da wannan dabarar niyya," in ji Jared Bearss, COO na Halia. "Ikon duka biyun hana taron da kuma inganta rarrabawar NLRP3 inflammasome hadaddun yana wakiltar babbar dama don samar da sababbin hanyoyin kwantar da hankali ga marasa lafiya da ke fama da cututtukan cututtuka da cututtuka."

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...